STEMart Announces Enhanced In Vivo Rat Micronucleus Test Services to Accelerate Medical Device Biocompatibility Testing
STEMart announces the expansion of its genetic toxicology capabilities with the In Vivo Rat Micronucleus Test services. NEW YORK, NY, UNITED STATES, January 26, 2026 /EINPresswire.com/ -- STEMart, a US-based provider of comprehensive services for all …